Panelists John Marshall, MD; Johanna Bendell, MD; Tanios Bekaii-Saab, MD; and Alan P. Venook, MD, discuss the need for longer-term strategies in metastatic colorectal cancer because of an increased likelihood that a patient will need a third line of therapy.